Actively Recruiting
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
Led by Roswell Park Cancer Institute · Updated on 2026-01-29
160
Participants Needed
1
Research Sites
167 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial evaluates the impact of an education and navigation support tool (ENST) on patient and caregiver participation in care coordination for bladder cancer that has spread to nearby tissue or lymph nodes (locally advanced), to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Patients with advanced bladder cancer tend to be older, have multiple medical conditions and often have poor access to health care. An ENST may be an effective method to improve participation in treatment decision-making and care planning among patients with locally advanced, metastatic and unresectable bladder cancer and their caregivers.
CONDITIONS
Official Title
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Patients with metastatic, locally advanced, or unresectable bladder cancer
- Patients receiving or planning to receive systemic therapy for bladder cancer at Roswell Park Comprehensive Cancer Center
- Patients enrolling any time from initial diagnosis of advanced disease to within 8 weeks after starting first-line systemic therapy
- Patients able to speak, understand, read, and write English
- Caregivers aged 18 years or older
- Caregivers of enrolled patients only
- Caregivers able to speak, understand, read, and write English
- Caregivers enrolling during the same time window as patients (from initial visit to within 8 weeks of patients starting frontline therapy)
You will not qualify if you...
- Patients not receiving systemic therapy due to ECOG performance status greater than 3, co-morbidities, or inadequate organ function
- Patients with predominantly small cell histology
- Patients with impaired decision-making capacity unable to participate in education and surveys
- Pregnant women
- Caregivers with cognitive impairment or impaired decision-making capacity
- Caregivers who are not adults (infants, children, teenagers)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here